316 related articles for article (PubMed ID: 28488774)
1. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
Wang L; Jia Y; Jiang Z; Gao W; Wang B
Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
[TBL] [Abstract][Full Text] [Related]
2. FSCN1 Promotes Epithelial-Mesenchymal Transition Through Increasing Snail1 in Ovarian Cancer Cells.
Li J; Zhang S; Pei M; Wu L; Liu Y; Li H; Lu J; Li X
Cell Physiol Biochem; 2018; 49(5):1766-1777. PubMed ID: 30231243
[TBL] [Abstract][Full Text] [Related]
3. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas.
Gasparotto D; Polesel J; Marzotto A; Colladel R; Piccinin S; Modena P; Grizzo A; Sulfaro S; Serraino D; Barzan L; Doglioni C; Maestro R
Oncotarget; 2011 Dec; 2(12):1165-75. PubMed ID: 22201613
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
[TBL] [Abstract][Full Text] [Related]
7. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
8. Slug (SNAI2) expression in oral SCC cells results in altered cell-cell adhesion and increased motility.
Katafiasz D; Smith LM; Wahl JK
Cell Adh Migr; 2011; 5(4):315-22. PubMed ID: 21785273
[TBL] [Abstract][Full Text] [Related]
9. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells.
Liu S; Zhou F; Shen Y; Zhang Y; Yin H; Zeng Y; Liu J; Yan Z; Liu X
Oncotarget; 2016 May; 7(22):32876-92. PubMed ID: 27096955
[TBL] [Abstract][Full Text] [Related]
10. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas.
Yokoyama K; Kamata N; Fujimoto R; Tsutsumi S; Tomonari M; Taki M; Hosokawa H; Nagayama M
Int J Oncol; 2003 Apr; 22(4):891-8. PubMed ID: 12632084
[TBL] [Abstract][Full Text] [Related]
11. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.
Mandal M; Myers JN; Lippman SM; Johnson FM; Williams MD; Rayala S; Ohshiro K; Rosenthal DI; Weber RS; Gallick GE; El-Naggar AK
Cancer; 2008 May; 112(9):2088-100. PubMed ID: 18327819
[TBL] [Abstract][Full Text] [Related]
12. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
13. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
[TBL] [Abstract][Full Text] [Related]
14. p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinoma.
Lin Y; Mallen-St Clair J; Wang G; Luo J; Palma-Diaz F; Lai C; Elashoff DA; Sharma S; Dubinett SM; St John M
Oral Oncol; 2016 Sep; 60():81-9. PubMed ID: 27531877
[TBL] [Abstract][Full Text] [Related]
15. FSCN1 and epithelial mesenchymal transformation transcription factor expression in human pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
Morris HT; Bamlet WR; Razidlo GL; Machesky LM
Pathol Res Pract; 2023 Nov; 251():154836. PubMed ID: 37832352
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
[TBL] [Abstract][Full Text] [Related]
17. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
[TBL] [Abstract][Full Text] [Related]
18. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
20. EMT-related transcription factors and protein stabilization mechanisms involvement in cadherin switch of head and neck squamous cell carcinoma.
Ingruber J; Dudás J; Savic D; Schweigl G; Steinbichler TB; Greier MDC; Santer M; Carollo S; Trajanoski Z; Riechelmann H
Exp Cell Res; 2022 May; 414(1):113084. PubMed ID: 35219646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
